
Christopher W. Fulton
Examiner (ID: 16699, Phone: (571)272-2242 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2859, 3641, 2406, 2899, 2841, 2855, 3108, 2856 |
| Total Applications | 3373 |
| Issued Applications | 2875 |
| Pending Applications | 85 |
| Abandoned Applications | 419 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6636412
[patent_doc_number] => 20100035825
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-11
[patent_title] => 'Treatment Of Disease By Inducing Cell Apoptosis'
[patent_app_type] => utility
[patent_app_number] => 12/189526
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 27510
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20100035825.pdf
[firstpage_image] =>[orig_patent_app_number] => 12189526
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/189526 | Treatment of disease by inducing cell apoptosis | Aug 10, 2008 | Issued |
Array
(
[id] => 5416921
[patent_doc_number] => 20090042808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'USE OF MITOCHONDRIA-TARGETED ELECTRON SCAVENGERS AS ANTI-INFLAMMATORY AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/188369
[patent_app_country] => US
[patent_app_date] => 2008-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12186
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20090042808.pdf
[firstpage_image] =>[orig_patent_app_number] => 12188369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/188369 | Use of mitochondria-targeted electron scavengers as anti-inflammatory agents | Aug 7, 2008 | Issued |
Array
(
[id] => 6400954
[patent_doc_number] => 20100305024
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'METHODS OF INHIBITING CALCINEURIN WITH APOE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 12/671433
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 16125
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20100305024.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671433
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671433 | Methods of inhibiting calcineurin with ApoE analogs | Jul 30, 2008 | Issued |
Array
(
[id] => 4596217
[patent_doc_number] => 07981911
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-19
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => utility
[patent_app_number] => 12/183507
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 9445
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/981/07981911.pdf
[firstpage_image] =>[orig_patent_app_number] => 12183507
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/183507 | Pharmaceutical formulations | Jul 30, 2008 | Issued |
Array
(
[id] => 8232967
[patent_doc_number] => 08198405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Stabilized alpha helical peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/182673
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 83
[patent_no_of_words] => 19120
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/198/08198405.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182673 | Stabilized alpha helical peptides and uses thereof | Jul 29, 2008 | Issued |
Array
(
[id] => 8875815
[patent_doc_number] => 08470781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Use of effectors of glutaminyl and glutamate cyclases'
[patent_app_type] => utility
[patent_app_number] => 12/182113
[patent_app_country] => US
[patent_app_date] => 2008-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 27357
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12182113
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182113 | Use of effectors of glutaminyl and glutamate cyclases | Jul 28, 2008 | Issued |
Array
(
[id] => 9832048
[patent_doc_number] => 08940865
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-01-27
[patent_title] => 'Myocardial peptide, preparation method and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/054229
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 7393
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13054229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/054229 | Myocardial peptide, preparation method and uses thereof | Jul 14, 2008 | Issued |
Array
(
[id] => 4960592
[patent_doc_number] => 20080275017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/173235
[patent_app_country] => US
[patent_app_date] => 2008-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4690
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20080275017.pdf
[firstpage_image] =>[orig_patent_app_number] => 12173235
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/173235 | AROMATIC SULFENATES FOR TYPE I PHOTOTHERAPY | Jul 14, 2008 | Abandoned |
Array
(
[id] => 5429078
[patent_doc_number] => 20090088388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'Peptides for Use In Treating Obesity'
[patent_app_type] => utility
[patent_app_number] => 12/168993
[patent_app_country] => US
[patent_app_date] => 2008-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19409
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088388.pdf
[firstpage_image] =>[orig_patent_app_number] => 12168993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/168993 | Peptides for Use In Treating Obesity | Jul 7, 2008 | Abandoned |
Array
(
[id] => 4644436
[patent_doc_number] => 08022041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-20
[patent_title] => 'Prodrug of an ICE inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/165838
[patent_app_country] => US
[patent_app_date] => 2008-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8036
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/022/08022041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12165838
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/165838 | Prodrug of an ICE inhibitor | Jun 30, 2008 | Issued |
Array
(
[id] => 6352455
[patent_doc_number] => 20100249370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'PROCESS FOR THE PRODUCTION OF PRAMLINTIDE'
[patent_app_type] => utility
[patent_app_number] => 12/665844
[patent_app_country] => US
[patent_app_date] => 2008-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3367
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249370.pdf
[firstpage_image] =>[orig_patent_app_number] => 12665844
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/665844 | PROCESS FOR THE PRODUCTION OF PRAMLINTIDE | Jun 29, 2008 | Abandoned |
Array
(
[id] => 5297051
[patent_doc_number] => 20090011977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Novel Lipopeptides as Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 12/163225
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22475
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0011/20090011977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12163225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/163225 | Novel Lipopeptides as Antibacterial Agents | Jun 26, 2008 | Abandoned |
Array
(
[id] => 4779349
[patent_doc_number] => 20080287347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Novel Lipopeptides as Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 12/163299
[patent_app_country] => US
[patent_app_date] => 2008-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22463
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287347.pdf
[firstpage_image] =>[orig_patent_app_number] => 12163299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/163299 | Novel Lipopeptides as Antibacterial Agents | Jun 26, 2008 | Abandoned |
Array
(
[id] => 9245534
[patent_doc_number] => 08609814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'Modified globin proteins with altered electron transport pathway'
[patent_app_type] => utility
[patent_app_number] => 12/452075
[patent_app_country] => US
[patent_app_date] => 2008-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 9584
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452075
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/452075 | Modified globin proteins with altered electron transport pathway | Jun 25, 2008 | Issued |
Array
(
[id] => 4682799
[patent_doc_number] => 20080249025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Methods and Means For Inhibition of CDK4 Activity'
[patent_app_type] => utility
[patent_app_number] => 12/133242
[patent_app_country] => US
[patent_app_date] => 2008-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 18918
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249025.pdf
[firstpage_image] =>[orig_patent_app_number] => 12133242
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/133242 | Methods and Means For Inhibition of CDK4 Activity | Jun 3, 2008 | Abandoned |
Array
(
[id] => 5337867
[patent_doc_number] => 20090054331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'HIGH TEMPERATURE STABLE PEPTIDE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 12/129504
[patent_app_country] => US
[patent_app_date] => 2008-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7807
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054331.pdf
[firstpage_image] =>[orig_patent_app_number] => 12129504
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/129504 | High temperature stable peptide formulation | May 28, 2008 | Issued |
Array
(
[id] => 8664402
[patent_doc_number] => 08377863
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Peptide pharmaceutical for oral delivery'
[patent_app_type] => utility
[patent_app_number] => 12/128210
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10672
[patent_no_of_claims] => 83
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12128210
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128210 | Peptide pharmaceutical for oral delivery | May 27, 2008 | Issued |
Array
(
[id] => 8164513
[patent_doc_number] => 08173605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Kokumi-imparting agent'
[patent_app_type] => utility
[patent_app_number] => 12/117027
[patent_app_country] => US
[patent_app_date] => 2008-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11895
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 192
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12117027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/117027 | Kokumi-imparting agent | May 7, 2008 | Issued |
Array
(
[id] => 5404494
[patent_doc_number] => 20090239808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-24
[patent_title] => 'CALCIUM RECEPTOR ACTIVATOR'
[patent_app_type] => utility
[patent_app_number] => 12/117041
[patent_app_country] => US
[patent_app_date] => 2008-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8079
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20090239808.pdf
[firstpage_image] =>[orig_patent_app_number] => 12117041
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/117041 | Calcium receptor activator | May 7, 2008 | Issued |
Array
(
[id] => 6339638
[patent_doc_number] => 20100247482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'TIGHT JUNCTION MODULATOR PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/108452
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14338
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108452
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108452 | TIGHT JUNCTION MODULATOR PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS | Apr 22, 2008 | Abandoned |